Mesenchymal Stem Cells

Regenerative Medicine for Systemic Lupus Erythematosus: A New Frontier in Treatment

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can damage many different parts of the body, including the kidneys, lungs, brain, and blood system. Because it can attack so many organs, it often leads to serious illness and even death.  For many years, doctors have used medications like corticosteroids, cyclophosphamide (CTX), and mycophenolate…

Mesenchymal Stem Cells for Spinal Cord Injury: Mechanisms, Advances, and Future Challenges

Spinal cord injury (SCI) is one of the most serious outcomes of spinal trauma. It typically leads to either temporary or permanent loss of sensory, motor, and autonomic nerve functions below the affected area and can significantly impact a person's quality of life. Worldwide, approximately 10.5 out of every 100,000 people experience SCI. While modern…

The Potential of Mesenchymal Stem Cells in Parkinson’s Disease Treatment

Parkinson's disease (PD) is a neurodegenerative disorder affecting millions worldwide, causing debilitating symptoms such as tremors, rigidity, and difficulty walking. Existing treatments primarily manage symptoms without addressing the underlying causes, highlighting the need for more effective therapeutic approaches. Mesenchymal stem cell (MSC) therapy has emerged as a promising option, demonstrating potential neuroprotective, anti-inflammatory, and regenerative…

Mesenchymal Stem Cells and Spinal Cord Injury: A Promising Path to Recovery

Spinal cord injury (SCI) is a devastating condition that causes severe nerve damage, leading to impaired movement, sensation, and bodily functions. The injury sets off a series of damaging processes, including excessive inflammation, loss of essential nutrients, and scar tissue formation.  These factors prevent the regeneration of nerve cells, making recovery difficult. Traditional treatments provide…

Advancements in Mesenchymal Stem Cell Applications for Traumatic Spinal Cord Injury: A Systematic Clinical Review

Spinal cord injury (SCI) can lead to lasting health challenges, impacting motor, sensory, and autonomic functions. Recovery from such injuries is particularly difficult due to the central nervous system's limited ability to repair itself. As a result, scientists have turned to stem cell therapies, particularly mesenchymal stem cells (MSCs), as a potential solution to help…

Alcoholic Liver Disease (ALD): An Overview and Emerging Treatments

Alcoholic liver disease (ALD) is a serious global health problem that arises from chronic or binge alcohol consumption. As a chronic liver disease, ALD occurs due to alcohol's harmful effects on the liver, which is the first organ to metabolize alcohol. This process leads to the production of harmful byproducts that damage liver cells and…

Exploring Regenerative Medicine for Progressive Multiple Sclerosis

Progressive multiple sclerosis (PMS) is a complex, disabling form of multiple sclerosis characterized by the progressive accumulation of central nervous system (CNS) damage. This damage arises from chronic inflammation, demyelination, axonal injury, neuronal degeneration, and gliosis, affecting both white and gray matter in the brain and spinal cord. Despite advancements in MS research, effective reparative…

Evaluating Regenerative Medicine for Degenerative Disc Disease and Low Back Pain

Back pain is the most common cause of disability worldwide, impacting people of all ages and socioeconomic backgrounds. In North America, it is one of the top reasons people miss work and visit doctors. Studies show that at least 80% of Americans will experience low back pain at some point in their lives, making it…

Clinical Application of Mesenchymal Stem Cells in Autoimmune Conditions

The onset of autoimmune diseases is related to unbalanced immune homeostasis and leads to the injury and failure of several organ specific tissues. Currently estimated to affect 8-10% of the population, these autoimmune diseases are associated with serious impairment, high mortality rate, and significant medical costs. The discovery of stem cells, and specifically mesenchymal stem…

Chondrocyte and Mesenchymal Stem Cell-Based Therapies to Help Manage in Osteoarthritis and Other Orthopedic Conditions 

Osteoarthritis (OA) continues to be the most common form of degenerative joint disease in the United States and around the world.  According to the World Health Organization (WHO), 528 million people worldwide were living with osteoarthritis (OA) in 2019, which is an increase of 113% since 1990. The Global Burden of Disease Study 2021 found…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.